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Background: Endoscopic retrograde cholangiopancreatography (ERCP) is an important therapeutic mo-
dality in acute biliary pancreatitis (ABP) cases with cholangitis or ongoing common bile duct obstruction.
Theoretically, inflammation of the surrounding tissues would result in a more difficult procedure. No
previous studies examined this hypothesis.
Objectives: ABP and acute cholangitis (AC) without ABP cases were compared to assess difficulty of ERCP.
Methods: The rate of successful biliary access, advanced cannulation method, adverse events, cannula-
tion and fluoroscopy time were compared in 240 ABP cases and 250 AC cases without ABP. Previous
papillotomy, altered gastroduodenal anatomy, and cases with biliary stricture were excluded.
Results: Significantly more pancreatic guidewire manipulation (adjusted odds ratio (aOR) 1.921 [1.241
e2.974]) and prophylactic pancreatic stent use (aOR 4.687 [2.415e9.098]) were seen in the ABP than in
AC group. Average cannulation time in the ABP patients (248 vs. 185 s; p ¼ 0.043) were longer than in AC
cases. No difference was found between biliary cannulation and adverse events rates.
Conclusion: ERCP in ABP cases seem to be more challenging than in AC. Difficult biliary access is more
frequent in the ABP cases which warrants the involvement of an experienced endoscopist.
© 2020 IAP and EPC. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Endoscopic retrograde cholangiopancreatography (ERCP) is an
invaluable minimal invasive therapeutic modality which changed
the management of several pancreato-biliary disorders [1]. In acute
cholangitis (AC), early achievement of biliary drainage is associated
with better outcomes, especially in severe, septic cases as stated in
the new 2018 Tokyo guideline for acute cholangitis [2]. In acute
biliary pancreatitis (ABP), the role of ERCP is more ambiguous,Hungary.
B.V. This is an open access article uwhen AC is also present early intervention is indicated, however, in
cases with biliary obstruction only, the need for an early ERCP is
questionable. The recent Dutch randomized controlled APEC trial,
came to the conclusion that in patients with predicted severe acute
biliary pancreatitis, early (<24 h) ERCP did not reduce rate of death
and major complications [3].
Nevertheless, ERCP plays a significant role in themanagement of
AC and ABP [4]. It is a common experience that in cases of ABP,
duodenal and pancreatic edema might result in more difficult
cannulation. There are some attempts to objectively grade the
difficulty of ERCP, e.g., in the consensus-based ASGE grading system
cases of acute pancreatitis get a higher, 3 points. However, no
supporting data was found to this classification claim besides thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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based on their center’s data and found that procedural success and
complications correlate well with the ASGE grades [6]. The previ-
ously widely used Schutz [7] and the newer HO.U.S.E. classification
does not contain ABP as a factor for more complicated procedures
[8].
For that reason, we intended to analyze data from the Hungarian
ERCP Registry to quantify the difficulty of ABP cases compared to AC
cases without pancreatitis.Methods
General cohort from the Hungarian ERCP registry
Prospectively collected data from the Hungarian ERCP Registry
were analyzed in this cohort study comparing ABP and AC cases.
The Hungarian Endoscopy Study Group initiated the project of the
Hungarian ERCP Registry in 2016 [9] and the number of partici-
pating centers growing gradually since then. Cases from 7 tertiary
referral centers and 15 endoscopists were uploaded into the Reg-
istry (Suppl. Table 1). Quality indicators laid down by European and
American Societies of Gastroenterology (ESGE and ASGE) were
mostly met by our centers showing general good practice of ERCP
[10,11], only NSAID suppository usage was significantly lower,
while bleeding and perforation were somewhat higher than ex-
pected (Suppl. Table 2). All participating endoscopists uploaded all
ERCP cases which were done by them consecutively, no trainee
participation was recorded. Recruitment period lasted from
September 2016 till April 2019. A 30-day telephone follow-up was
carried out to detect late adverse events. Data quality was assured
by a 4-step checking system built in the Registry (1: local check
from administrator, 2: endoscopist, 3: central check by chief
administrator, 4: registry coordinator (AV)) (more information is
available at https://tm-centre.org/en/registries/ercp-registry/) [9]
(Suppl. Table 3). The use of different cannulation methods could be
found in Suppl. Table 4.
The Hungarian ERCP Registry has been ethically approved by the
Scientific and Research Ethics Committee of the Medical Research
Council (TUKEB-35523/2016/EKU).Inclusion and exclusion criteria
Subjects with previous papillotomy, altered gastroduodenal
anatomy (surgery, gastro-duodenal obstruction), and biliary stric-
tures were excluded to reach a more homogenous patient popu-
lationwith biliary stones or sludge as main etiology. Based on these
exclusion criteria from the total of 2734 cases, finally, 240 ABP and
250 AC cases without ABP were available for analysis
(Suppl. Figure 1). Diagnosis of AC was established by the Tokyo
guidelines, while the diagnosis of ABP was based on imaging and
laboratory parameters, and other etiologies of pancreatitis wereTable 1
Comparison of the general characteristics of the cohort (ABP: acute biliary pancreatit
deviation).
ABP (n ¼
Mean age (SD) 63.13 (16.









Indications of ERCP were defined in the Registry protocol ac-
cording to international guidelines [2,4,11]. The definition of acute
pancreatitis was based on the IAP/APA guidelines [4]. Presence of
sludge or stone in the common bile duct and/or increase of bilirubin
and/or increase of transaminase levels and/or inflammatory pa-
rameters during repeated testing in 12e24 h intervals were the
indications of ERCP in both groups. Guidewire-assisted simple
cannulation technique was first attempted at initial cannulation, in
case of failure advanced cannulation methods (needle-knife precut,
PGW-assisted techniques) were tried. PPS insertionwas carried out
only in cases of difficult biliary access, after unintentional PGW
insertion. Cannulation algorithm laid down by ESGE was followed
in all centers [12]. Adverse events such as bleeding, perforation,
post-ERCP pancreatitis were defined as in the consensus paper
from Cotton et al. [13].
Analyzed dataset
Besides the baseline, demographic data (gender, age, American
Society of Anesthesiology (ASA) status), the presence of juxtapa-
pillary diverticulum (JPD), anticoagulation/antiplatelet medication
use, the rate of successful biliary access, the use of advanced can-
nulation methods, post-ERCP pancreatitis (PEP) prophylaxis mea-
sures (non-steroid suppositories, prophylactic pancreatic stent
placement), adverse event rates (bleeding, perforation, PEP), can-
nulation and fluoroscopy times were compared in the two groups.
This cohort study conforms with the STROBE guidelines [14].
Statistical analysis
Continuous measures are summarized and presented as means
and standard deviations (SD) or as median and interquartile ranges
(IQR). Categorical data are presented as observed and as percent-
ages. To determine differences between continuous parameters,
depending on the distribution of the data, we used the independent
Student’s t-test or the ManneWhitney U test for two groups. We
used the Chi-square test or Fisher’s exact test to analyze the re-
lations between the factors under examination and odds ratios
were also calculated. Binary logistic regression with stepwise for-
ward elimination was used to observe independent prognostic
factors from the followings: age, gender, study groups (ABP vs AC),
JPD and ASA score for the main outcomes (advanced cannulation
rate, pancreatic cannulation, pancreatic stent placement) where
significant differences were detected, and enough data was avail-
able. All analyses were performed with SPSS 25 statistical software
(IBM Corporation, Armonk, NY).
We performed a sample size calculation before the study wasis, AC: acute cholangitis, ASA: American Society of Anesthesiology, SD: standard
240) AC (n ¼ 250) p-value









Analysis of advanced cannulation method use and post-ERCP pancreatitis prophylaxis in the ABP and AC groups (ABP: acute biliary pancreatitis, AC: acute cholangitis, PGW:
pancreatic guidewire, PPS: prophylactic pancreatic stent, NK: needle knife, NSAID: non-steroidal anti-inflammatory drugs, OR: Odds ratio; 95%CI: 95% confidence interval).
ABP (n ¼ 240) AC (n ¼ 250) OR (95%CI) p-value adjusted OR (95%CI) p-value
Advanced biliary cannulation rate 108 (45.0%) 61 (24.4%) 2.54 (1.73, 3.72) <0.001 2.388 (1.691e3.522) <0.001













Sequential advanced methods needed 30/108 (27.8%) 13/61 (21.3%) 1.42 (0.68, 2.99) 0.354 e e
Primary PGW/PPS-assisted advanced method used 36/108 (33.3%) 14/61 (22.9%) 1.68 (0.82, 3.44) 0.156 e e
Primary NK advanced method used 72/108 (66.7%) 47/61 (77.0%) 0.60 (0.29, 1.22) 0.156 e e
PPS inserted 47 (19.6%) 12 (4.8%) 4.83 (2.49, 9.36) <0.001 4.687 (2.415e9.098) <0.001
NSAID suppository use 161 (67.1%) 155 (62.0%) 1.25 (0.86, 1.81) 0.240 e e
Table 3
Comparison of adverse event rates in the ABP and AC groups (ABP: acute biliary
pancreatitis, AC: acute cholangitis, N.A.: not applicable).
ABP (240) AC (250) p-value
Intraprocedural, immediate bleeding 23 (9.6%) 18 (7.2%) 0.341
Late, clinically significant bleeding 0 (0.0%) 2 (0.8%) 0.499
Conservatively managed perforation 2 (0.8%) 3 (1.2%) 1.000
Cholecystitis 3 (1.3%) 4 (1.6%) 1.000
Post-ERCP pancreatitis N.A. 3 (1.2%) N.A.
Fig. 1. Analysis of successful biliary access rate in all, simple cannulation and advanced
cannulation cases (ABP: acute biliary pancreatitis, AC: acute cholangitis).
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group (AC) 20% advanced cannulation rate could be expected and
we estimated the effect of ABP could increase the rate of advanced
cannulation by an odds ratio of 2 (33%). Calculating by a two-sided
significance level of 95%, 80% power, and the assumption
mentioned above, at least 187 ABP and 187 AC cases would be
needed to detect a significant difference. OpenEpi online calculator
was used to estimate the sample size (https://www.openepi.com/
SampleSize/SSCohort.htm).
Sensitivity analyses were carried out excluding ABP cases with
questionable indication of ERCP, i.e. cases where stone or sludge
were not detected during the ERCP to reinforce the robustness of
the results.
Results
General characteristics of the cohort
AC patients were significantly older than ABP patients (69.6 vs.
63.1 years, p < 0.001), while more women were in the ABP group
(60% vs. 50%) (Table 1; Suppl. Figure 2). A higher proportion of ASA I
patients was in the younger ABP group, while more ASA III patients
were in the older AC group. No significant difference was found in
the anticoagulation and antiplatelet usage between the two groups.
Interestingly, more juxtapapillary diverticula were observed in AC
patients (26.8% vs. 12.9%, p < 0.001) (Table 1).
Findings of ERCP
Normal cholangiogram was observed more frequently in ABP
than in AC cases (20.0% vs. 12.3%, p ¼ 0.026). Dilated common bile
duct (CBD) without stone or sludge was found during ERCP in a
higher proportion of ABP patients, compared to AC patients (22.6%
vs. 12.8%, respectively, p ¼ 0.005). The prevalence of biliary sludge
without stones and small CBD stones (10 mm) were not signifi-
cantly different in ABP and AC group (14.3% vs. 9.1% (p ¼ 0.073) and
39.1% vs. 46.9% (p ¼ 0.088), respectively). Large CBD stones were
present more commonly in AC patients (3.9% vs. 18.9%, p < 0.001).
Expectedly, purulent bile was more frequently found in AC cases
than in ABP cases (6.5% vs. 22.2%, p < 0.001) (Suppl. Table 5). No61stone extractionwas attempted, only a stent was inserted in 13/240
(5.4%) in ABP vs. 14/250 (5.6%) in AC cases, due to large stones or in
patients with clopidogrel or oral anticoagulant therapy.
Biliary cannulation success rates
Successful biliary access was achieved in ABP cases in 230/240
Fig. 2. Comparison of cannulation time (median, in seconds) and proportion of more
than 5-min cannulation time in the ABP and AC group (ABP: acute biliary pancreatitis,
AC: acute cholangitis).
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ERCP. Simple cannulation succeeded less frequently in the ABP
group (54.6% vs. 75.6%; p < 0.001), however, no difference was
found in the success rate of advanced cannulation methods in the
two groups (91.7% vs. 88.5%; p ¼ 0.503) (Fig. 1).Advanced cannulation methods and post-ERCP pancreatitis
prophylaxis
Advanced cannulation methods were used in 108/240 (45.0%)
cases of ABP, while only in 61/250 (24.4%) of AC cases (p < 0.001).
Multiple advancedmethods were used in 13/61 in AC and 30/108 in
ABP cases, respectively (p ¼ 0.354). More pancreatic duct manip-
ulations were found in the ABP group (31.3% vs. 17.2%, p < 0.001)
and also more prophylactic pancreatic stents (PPS) were inserted in
these patients (19.6% vs. 4.8%; p < 0.001). No difference was seen in
the NSAID suppository use between the two groups (67.1% vs. 62%;
p ¼ 0.240) (Table 2).
Carrying out a binary logistic regression for the main outcomes
(advanced cannulation rate, pancreatic cannulation, pancreatic
stent placement) did not change ORs significantly by the adjust-
ment (Table 2).
Excluding ABP cases with negative cholangiograms, the differ-
ences between the use of advanced cannulation methods (OR 2.47
[1.62e3.37], p < 0.001), pancreatic cannulation rate (OR 2.37
[1.52e3.70], p < 0.001), PPS insertion rate (OR 4.99 [2.53e9.83],
p < 0.001) remained significantly different between the two
groups.Adverse event rates
Only a low number of clinically significant bleeding (0% vs. 0.8%),
perforation (0.8% vs. 1.2%), cholecystitis (1.3% vs. 1.6%), immediate
bleeding (9.6% vs. 7.2%) were detected, and no significant difference
could be detected between the groups in this regard (Table 3).Fig. 3. Comparison of fluoroscopy times in the ABP and AC groups (median, in sec-
onds) (ABP: acute biliary pancreatitis, AC: acute cholangitis).Cannulation times
The average biliary cannulation time was significantly longer in
the ABP group (248 vs. 185 s, p ¼ 0.043) (Fig. 2), however, that
difference could not be found when the simple (113 vs. 116 s) or the
advanced cannulation time (409 vs. 396 s) were separately
analyzed. The number of more than 5-min cannulation was higher
in the ABP patients (28.2% vs. 19.3%; p ¼ 0.037) (Fig. 2), and with
normal cholangiograms, the cannulation lasted longer in the ABP
group (324 vs. 154 s; p ¼ 0.040). This difference could also be seen
in patients without JPD (261 vs. 158 s, p ¼ 0.005) (Suppl. Table 6).62Fluoroscopy time
Fluoroscopy time was longer in the AC group, when all cases
(91 s vs. 107 s; p ¼ 0.009) (Fig. 3), and the simple cannulation cases
(91 s vs. 107 s; p ¼ 0.008) were compared. When stone extraction
was done in AC patients, it took significantly longer, most probably
due to the higher rate of larger (>1 cm) stones (89 s vs. 107 s;
p ¼ 0.009). In other subgroups, no differences were found
(Suppl. Table 7).Discussion
Our data support the ASGE grading of difficulty for acute biliary
pancreatitis in ERCP. Several parameters suggest that ERCP is more
challenging in ABP cases than in AC cases. We found that the rate of
advanced cannulation method use and the rate of inadvertent
pancreatic cannulation were higher and cannulation time was
longer in ABP patients than in AC cases. This observation points to
the fact that we face difficult biliary cannulation in ABP more
frequently compared to AC cases, where similar pathologic changes
related to the biliary tree are expected. Importantly, the cannula-
tion success rate and the rate of adverse events were not influenced
by this. We also found a higher number of cases with normal
cholangiogram in the ABP group (20.0%) compared to AC (12.3%). In
these cases, spontaneous passage of stones or sludge by the time of
ERCP is one possible explanation for the initial worsening of
cholestatic parameters. Additionally, this also might be due to the
difficulty of diagnosing acute cholangitis when acute pancreatitis is
also present, but also can be explained by the suboptimal avail-
ability of preprocedural endoscopic ultrasound evaluation in the
participating Hungarian centers. ERCPs could have been avoided in
these cases, cost and avoidable invasiveness should be highlighted,
as a potential benefit [15]. Fluoroscopy time does not correlate with
the difficulty of biliary access in our study, more likely it depends on
D. Pecsi, S. Godi, P. Hegyi et al. Pancreatology 21 (2021) 59e63the occurrence and size of bile duct stones, since large stones were
more frequently found in the AC group.
Our study has several strengths, first of all, it is a quite large,
prospectively collected, nationwide dataset from several centers in
Hungary. Consecutively collected ABP and AC cases were available
in almost equal numbers with good data quality, detailed data set,
and in an appropriate sample size. Secondly, our registry system
has a built-in quality assurance program that could limit false data
entry and underreporting. Multivariable statistics also confirmed
the robustness of our findings.
There are some limitations to our study. Post hoc questions
raised in a prospective registry database might result in con-
founding effects. All cases come from high-volume centers and
endoscopists, and case distribution is varied among centers that
hinder generalizability (Suppl. Table 1). The inherent biases of
observational studies and retrospective designs e.g., selection bias
should be noted in our study as well. There were some differences
between the two groups, firstly, AC patients were older, and had
more comorbidities (more ASA III patients). Secondly, more juxta-
papillary diverticula were found in the AC group. For this reason,
binary logistic regression model was used to adjust for these dif-
ferences. Thirdly, the differentiation of AC cases in the ABP group
could not have been done due to the lack of reliable guidelines or
tools to confirm the presence of cholangitis in ABP [16]. We were
curious about the additional worsening effect of ABP on AC and
non-AC cases, but we could not reliably separately analyze
AC þ ABP and ABP cases without AC. These factors could somewhat
limit our analysis.
Based on our data, ABP cases should be handled by more
experienced endoscopists who are familiar with a wide range of
cannulation techniques, pancreatic guidewire assisted (double
guidewire and transpancreatic sphincterotomy), as well as needle
knife precut techniques [12,17,18]. To lower the worsening effect of
inducing more pancreatic edema, the insertion of a prophylactic
pancreas stent might potentially improve disease course [19].
Taken together, the grade 3 difficulty classification by ASGE
seems to be justified for the ABP cases, and these patients should
not be left to the less experienced endoscopists. Additionally,
determining the appropriate indication of ERCP is vital in ABP pa-
tients. Hence, we would like to emphasize the need for the broader
application of less invasive diagnostic tools (e.g., endoscopic ul-
trasound) in this patient population to decrease the number of
unnecessary ERCPs.
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